SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-19-032421
Filing Date
2019-05-29
Accepted
2019-05-29 16:18:39
Documents
43
Period of Report
2019-02-28

Document Format Files

Seq Description Document Type Size
1 10-K a19-8091_110k.htm 10-K 908910
2 EX-31.1 a19-8091_1ex31d1.htm EX-31.1 10186
3 EX-31.2 a19-8091_1ex31d2.htm EX-31.2 10132
4 EX-32.1 a19-8091_1ex32d1.htm EX-32.1 6171
5 EX-32.2 a19-8091_1ex32d2.htm EX-32.2 6166
  Complete submission text file 0001104659-19-032421.txt   2762521

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT bzyr-20190228.xml EX-101.INS 361721
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bzyr-20190228.xsd EX-101.SCH 33264
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bzyr-20190228_cal.xml EX-101.CAL 21347
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT bzyr-20190228_lab.xml EX-101.LAB 256802
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bzyr-20190228_pre.xml EX-101.PRE 172316
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bzyr-20190228_def.xml EX-101.DEF 87288
Mailing Address
Business Address 12000 RICHMOND AVE HOUSTON TX 77082
BURZYNSKI RESEARCH INSTITUTE INC (Filer) CIK: 0000724445 (see all company filings)

IRS No.: 760136810 | State of Incorp.: DE | Fiscal Year End: 0228
Type: 10-K | Act: 34 | File No.: 000-23425 | Film No.: 19862226
SIC: 2835 In Vitro & In Vivo Diagnostic Substances